"Pioneering for Patients" - Ignacio J. Amat

Ignacio J Amat completed a successful First in Human implant of CroiValve’ s DUO Tricuspid Coaptation Valve technology for the treatment of Tricuspid Regurgitation as part of its TANDEM I study in Europe. The procedure went smoothly, and Ignacio tweeted “Orthotopic valve therapies for tricuspid regurgitation in HCU Valladolid – Pioneering for patients”.

Picture from left to right: Dr. Martin Quinn, CMO CroiValve, Greg Campion R&D Engineer, CroiValve and Ignacio J Amat Santos, Director, Cardiac Catheterization and Interventional Cardiology- Hospital Clínico Valladolid - Spain